Cargando…
Progress in novel cognitive enhancers for cognitive aging and Alzheimer’s disease
Increased knowledge of the biology of synaptic function has led to the development of novel cognitive-enhancing therapeutic strategies with the potential for increased efficacy and safety. This editorial highlights a diverse array of approaches currently being explored to target cognitive dysfunctio...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979029/ https://www.ncbi.nlm.nih.gov/pubmed/24083622 http://dx.doi.org/10.1186/alzrt209 |
_version_ | 1782310672871194624 |
---|---|
author | Shineman, Diana W Carman, Aaron J Dacks, Penny A Lane, Rachel F Fillit, Howard M |
author_facet | Shineman, Diana W Carman, Aaron J Dacks, Penny A Lane, Rachel F Fillit, Howard M |
author_sort | Shineman, Diana W |
collection | PubMed |
description | Increased knowledge of the biology of synaptic function has led to the development of novel cognitive-enhancing therapeutic strategies with the potential for increased efficacy and safety. This editorial highlights a diverse array of approaches currently being explored to target cognitive dysfunction due to aging and/or Alzheimer’s disease. |
format | Online Article Text |
id | pubmed-3979029 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39790292014-04-09 Progress in novel cognitive enhancers for cognitive aging and Alzheimer’s disease Shineman, Diana W Carman, Aaron J Dacks, Penny A Lane, Rachel F Fillit, Howard M Alzheimers Res Ther Editorial Increased knowledge of the biology of synaptic function has led to the development of novel cognitive-enhancing therapeutic strategies with the potential for increased efficacy and safety. This editorial highlights a diverse array of approaches currently being explored to target cognitive dysfunction due to aging and/or Alzheimer’s disease. BioMed Central 2013-10-02 /pmc/articles/PMC3979029/ /pubmed/24083622 http://dx.doi.org/10.1186/alzrt209 Text en Copyright © 2013 BioMed Central Ltd. |
spellingShingle | Editorial Shineman, Diana W Carman, Aaron J Dacks, Penny A Lane, Rachel F Fillit, Howard M Progress in novel cognitive enhancers for cognitive aging and Alzheimer’s disease |
title | Progress in novel cognitive enhancers for cognitive aging and Alzheimer’s disease |
title_full | Progress in novel cognitive enhancers for cognitive aging and Alzheimer’s disease |
title_fullStr | Progress in novel cognitive enhancers for cognitive aging and Alzheimer’s disease |
title_full_unstemmed | Progress in novel cognitive enhancers for cognitive aging and Alzheimer’s disease |
title_short | Progress in novel cognitive enhancers for cognitive aging and Alzheimer’s disease |
title_sort | progress in novel cognitive enhancers for cognitive aging and alzheimer’s disease |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979029/ https://www.ncbi.nlm.nih.gov/pubmed/24083622 http://dx.doi.org/10.1186/alzrt209 |
work_keys_str_mv | AT shinemandianaw progressinnovelcognitiveenhancersforcognitiveagingandalzheimersdisease AT carmanaaronj progressinnovelcognitiveenhancersforcognitiveagingandalzheimersdisease AT dackspennya progressinnovelcognitiveenhancersforcognitiveagingandalzheimersdisease AT lanerachelf progressinnovelcognitiveenhancersforcognitiveagingandalzheimersdisease AT fillithowardm progressinnovelcognitiveenhancersforcognitiveagingandalzheimersdisease |